XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Note 9 - Share-based Compensation
3 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

9.          SHARE-BASED COMPENSATION

 

On March 31, 2017, the Company adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “Plan”) authorizing 2,000,000 shares of Common Stock for issuance as awards to employees, directors or consultants. In May 2019, the stockholders ratified an increase in the Plan authorizing an additional 2,100,000 shares of Common Stock, in June 2020 ratified an additional 1,900,000 shares of Common Stock, in June 2021 ratified an additional 1,500,000 shares of Common Stock and in June 2022 ratified an additional 1,500,000 shares of Common Stock, for a total of 9,000,000 shares subject to the Plan. At March 31, 2023, there were 2,735,102 shares of Common Stock remaining available for grant under the Plan.

 

The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan.

 

Stock Options

 

The following table summarizes stock option activity for the three months ended March 31, 2023:

 

           

Weighted Average

         
   

Options on

           

Remaining

   

Aggregate

 
   

Common

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term

   

Value

 

Outstanding January 1, 2023

    5,491,399     $ 3.72       5.96     $ 92  

Granted

    -     $ 0                  

Exercised

    (250 )   $ 1.50                  

Forfeited, cancelled, expired

    (1,300,287 )   $ 5.33                  

Outstanding March 31, 2023

    4,190,862     $ 3.15       7.49     $ 98  

Exercisable March 31, 2023

    1,299,771     $ 3.74       4.11     $ 96  

 

At March 31, 2023, there were 2,576,632 service-based stock options outstanding, and 1,614,230 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s former Chief Executive Officer and President, subject to future market capitalization targets. 1,049,145 of the 4,190,862 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant, but are subject to the terms and conditions of the Plan.

 

The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:

 

   

For the Three Months

 
   

Ended March 31,

 
   

2023

   

2022

 

Expected stock price volatility

    0

%

    49

%

Risk-free interest rate

    0

%

    1.57

%

Expected dividend yield

    0

%

    0

%

Expected life of options - years

    0       1.39  

Weighted-average fair value of options granted

  $ 0     $ 1.72  

 

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred.

 

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero is based on the fact that the Company has never paid cash dividends and has no present intention to pay cash dividends. The Company calculates the expected life of the options using the Simplified Method for the employee stock options as the Company does not have sufficient historical exercise data.

 

The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s former Chief Executive Officer and President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years.

 

Stock option expense was $313 and $737 for the three months ended March 31, 2023 and 2022, respectively.

 

Restricted Stock Units

 

The Plan provides for the grant of restricted stock units (“RSUs”). RSUs are settled in shares of the Company’s Common Stock as the RSUs become vested. The following table summarizes RSU activity for the three months ended March 31, 2023:

 

           

Weighted Average

   

Weighted Average

 
   

Service-Based

   

Grant Date

   

Vesting

 
   

RSU's

   

Fair Value

   

Period (Years)

 

Unvested at January 1, 2023

    922,057     $ 2.88       2.11  

Granted - service based

    124,862     $ 1.84          

Vested

    (106,565 )   $ 2.87          

Forfeited and cancelled

    (3,386 )   $ 5.52          

Unvested at March 31, 2023

    936,968     $ 2.56       1.99  

 

RSU expense was $315 and $291 for the three months ended March 31, 2023 and 2022, respectively.

 

Share-Based Compensation Expense

 

The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:

 

   

Three Months Ended

March 31,

 
   

2023

   

2022

 

Selling, general and administrative

  $ 562     $ 894  

Research and development

    66       135  

Total share-based expense

  $ 628     $ 1,029  

 

As of March 31, 2023, total estimated compensation cost of stock options granted and outstanding but not yet vested was $3,061 which is expected to be recognized over the weighted average period of 3.23 years. As of March 31, 2023, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $1,700 which is expected to be recognized over the weighted average period of 1.99 years.